NASDAQ · Analyst Forecast

NovoCure Limited (NVCR) Stock Forecast & Price Target

$11.14 NASDAQ: NVCR Market Cap $1.30B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering NovoCure Limited (NVCR), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For NovoCure Limited, analysts forecast revenue rising from $655.40M in 2025 to $1.74B in 2030; the average estimate for 2030 earnings per share is $4.53; with published estimates ranging from $4.37 to $4.77; 6 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$11.14
Consensus targetThe average of the price targets analysts have published.$26.00
Median targetThe middle target, less affected by a single outlier.$26.00
Highest targetThe most optimistic published target.$32.00
Lowest targetThe most pessimistic published target.$20.00
Difference from priceHow far the consensus target sits from today’s price.+133.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$650.97M$655.40M$656.88M6
2026$740.32M$740.80M$741.27M5
2027$774.54M$799.33M$835.22M6
2028$821.72M$891.12M$978.83M6
2029$1.37B$1.41B$1.46B4
2030$1.69B$1.74B$1.81B3

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.46−$1.40−$1.306
2026−$1.17−$1.05−$0.995
2027−$1.20−$0.76−$0.276
2028−$0.74−$0.37$0.026
2029$1.83$1.90$2.004
2030$4.37$4.53$4.773

NovoCure Limited (NVCR) forecast — frequently asked questions

What is the analyst price target for NovoCure Limited?

Analysts covering NovoCure Limited (NVCR) have a consensus price target of $26.00, 133.4% above the current price of $11.14. Published targets range from $20.00 to $32.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for NovoCure Limited's earnings?

The average analyst estimate for NovoCure Limited (NVCR) earnings per share in 2030 is 4.53, with individual estimates between 4.37 and 4.77.

How much revenue is NovoCure Limited expected to make?

Analysts forecast NovoCure Limited (NVCR) revenue of $1.74B in 2030, based on 3 published estimates.

How many analysts cover NVCR?

6 analysts contribute estimates for NovoCure Limited (NVCR). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Instruments & Supplies stocks

BDX forecastMDLN forecastWST forecastSOLV forecastBAX forecastCOO forecastRGEN forecastAVTR forecastATR forecastBLCO forecastAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.